National Institute of Mental Health; Notice of Closed Meetings, 26108-26109 [2017-11591]
Download as PDF
<![CDATA[
26108
Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices
vulnerable and underserved
populations. The close proximity,
comparable medical services provided,
and Waterbury Hospital Health Center’s
relationship will Staywell Health Care,
Inc., will ensure a seamless transition of
RWHAP patients served by Waterbury
Hospital Health Center. Up to $426,543
will be awarded to Staywell Health
Care, Inc., in FY 2017, pending the
availability of appropriated funds. Not
issuing this award would result in the
disruption of comprehensive HIV
primary care and support services for
low income, underinsured, and
uninsured people living with HIV in the
service area.
Dated: June 1, 2017.
Dr. George Sigounas,
Administrator.
[FR Doc. 2017–11707 Filed 6–5–17; 8:45 am]
BILLING CODE 4165–15–P
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherrette Funn, Sherrette.Funn@hhs.gov
or (202) 795–7714.
Office of the Secretary
Agency Information Collection
Activities; Submission to OMB for
Review and Approval; Public Comment
Request
Office of the Secretary, HHS.
Notice.
AGENCY:
ACTION:
When
submitting comments or requesting
information, please include the
document identifier 0990–0278–30D for
reference.
Type of Collection Request: Extension
of Currently Approved Collection
Title of the Collection: Federalwide
Assurance Forms—Extension OMB No.
0990–0278, Assistant Secretary for
Health, Office for Human Research
Protections.
Abstract: The Office for Human
Research Protections is requesting a
three year extension of the Federalwide
Assurance (FWA). The FWA is designed
to provide a simplified procedure for
institutions engaged in HHS-conducted
or supported research to satisfy the
assurance requirements of Section
491(a) of the Public Health Service Act
and HHS Regulations for the protection
of human subjects at 45 CFR 46.103.
The respondents are institutions
engaged in human subjects research that
is conducted or supported by HHS.
Affected Public: Individuals or
households, business or other for-profit,
not-for-profit institutions, Federal, State,
Local, or Tribal Governments;
SUPPLEMENTARY INFORMATION:
[Document Identifier: 0990–0278–30D]
In compliance with the
Paperwork Reduction Act of 1995, the
Office of the Secretary (OS), Department
of Health and Human Services, has
submitted an Information Collection
Request (ICR), described below, to the
Office of Management and Budget
(OMB) for review and approval. The ICR
is for renewal of the approved
information collection assigned OMB
control number 0990–0278, scheduled
to expire on August 31, 2017. Comments
submitted during the first public review
of this ICR will be provided to OMB.
OMB will accept further comments from
the public on this ICR during the review
and approval period.
DATES: Comments on the ICR must be
received on or before July 6, 2017.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
SUMMARY:
ESTIMATED ANNUALIZED BURDEN IN HOURS TABLE
Number of
responses
per
respondent
Number of
respondents
Form name
Hours per
response
Response
burden hours
Federalwide Assurance (FWA) ........................................................................
14,000
2.0
0.50
14,000
Total ..........................................................................................................
........................
........................
........................
14,000
Terry S. Clark,
Asst. Paperwork Reduction Act Clearance
Officer.
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2017–11583 Filed 6–5–17; 8:45 am]
BILLING CODE 4150–36–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK30JT082PROD with NOTICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
VerDate Sep<11>2014
22:57 Jun 05, 2017
Jkt 241001
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; NIH
Pathway to Independence Awards (K99/R00).
Date: June 29, 2017.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Contact Person: David M. Armstrong,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center/
Room 6138/MSC 9608, 6001 Executive
Boulevard, Bethesda, MD 20892–9608, 301–
443–3534, armstrda@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services
Interventions (R01).
Date: June 30, 2017.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Aileen Schulte, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6140, MSC 9608,
E:\FR\FM\06JNN1.SGM
06JNN1
Federal Register / Vol. 82, No. 107 / Tuesday, June 6, 2017 / Notices
Bethesda, MD 20892–9608, 301–443–1225,
aschulte@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; Pilot
Effectiveness Trials for Treatment, Preventive
and Services Interventions (R34).
Date: June 30, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar, 2121 P Street NW.,
Washington, DC 20037.
Contact Person: Karen Gavin-Evans, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Boulevard, Room 6153, MSC
9606, Bethesda, MD 20892, 301–451–2356,
gavinevanskm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants; 93.281)
Dated: May 31, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–11591 Filed 6–5–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
mstockstill on DSK30JT082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Member Conflict Review
Panel.
Date: June 5, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Alexandria Hotel,
1900 Diagonal Road, Alexandria, VA 22314.
Contact Person: William Benzing, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–0660, benzingw@mail.nih.gov.
VerDate Sep<11>2014
20:52 Jun 05, 2017
Jkt 241001
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 31, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–11596 Filed 6–5–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Arthritis and
Musculoskeletal and Skin Diseases Initial
Review Group; Arthritis and Musculoskeletal
and Skin Diseases Special Grants Review,
Committee.
Date: June 22–23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Contact Person: Helen Lin, Ph.D.,
Scientific Review Officer, NIH/NIAMS/RB,
6701 Democracy Blvd., Suite 800, Plaza One,
Bethesda, MD 20817, 301–594–4952, linh1@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
Musculoskeletal and Skin Diseases Research,
National Institutes of Health, HHS)
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
26109
Dated: May 31, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–11598 Filed 6–5–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Network Clinical Trials.
Date: June 23, 2017.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Initial
Review Group; Neurological Sciences and
Disorders K.
Date: June 23, 2017.
Time: 3:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Shanta Rajaram, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529, (301)
496–6033, rajarams@mail.nih.gov.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Diversity F99 Review.
E:\FR\FM\06JNN1.SGM
06JNN1
]]>Agencies
[Federal Register Volume 82, Number 107 (Tuesday, June 6, 2017)]
[Notices]
[Pages 26108-26109]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11591]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; NIH Pathway to Independence Awards (K99/R00).
Date: June 29, 2017.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health Neuroscience Center, 6001
Executive Boulevard, Rockville, MD 20852 (Telephone Conference
Call).
Contact Person: David M. Armstrong, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center/Room 6138/MSC 9608, 6001
Executive Boulevard, Bethesda, MD 20892-9608, 301-443-3534,
armstrda@mail.nih.gov.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Clinical Trials to Test the Effectiveness of
Treatment, Preventive, and Services Interventions (R01).
Date: June 30, 2017.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, 2121 P Street NW., Washington, DC 20037.
Contact Person: Aileen Schulte, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room
6140, MSC 9608,
[[Page 26109]]
Bethesda, MD 20892-9608, 301-443-1225, aschulte@mail.nih.gov.
Name of Committee: National Institute of Mental Health Special
Emphasis Panel; Pilot Effectiveness Trials for Treatment, Preventive
and Services Interventions (R34).
Date: June 30, 2017.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hotel Palomar, 2121 P Street NW., Washington, DC 20037.
Contact Person: Karen Gavin-Evans, Ph.D., Scientific Review
Officer, Division of Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center, 6001 Executive Boulevard,
Room 6153, MSC 9606, Bethesda, MD 20892, 301-451-2356,
gavinevanskm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental
Health Research Grants; 93.281)
Dated: May 31, 2017.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-11591 Filed 6-5-17; 8:45 am]
BILLING CODE 4140-01-P
